Profiling of genes expressed by PTEN haploinsufficient neural precursor cells

Molecular and Cellular Neuroscience

Volumn 24, Issue 4, 2003, Pages 1051-1061

  Li, Li ^a   He, Feng ^a   Litofsky, N Scott ^a   Recht, Larry D ^a   Ross, Alonzo H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLECORTIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR; VASCULOTROPIN ANTIBODY;

ARTICLE; BRAIN VENTRICLE; CELL CULTURE; CYTOSKELETON; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; METABOLISM; NERVE CELL; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; UPREGULATION;

EID: 0345863401     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.08.010     Document Type: Article

References (68)

1. Altman J., Das G.D. Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions. J. Comp. Neurol. 126:1966;337-390.
2. Bachelder R.E., Wendt M.A., Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62:2002;7203-7206.
3. Backman S.A., Stambolic V., Suzuki A., Haight J., Elia A., Pretorius J., Tsao M.S., Shannon P., Bolon B., Ivy G.O., Mak T.W. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29:2001;396-403.
4. Benraiss A., Chmielnicki E., Lerner K., Roh D., Goldman S.A. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J. Neurosci. 21:2001;6718-6731.
5. Bringold F., Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35:2000;317-329.
6. Conover J.C., Doetsch F., Garcia-Verdugo J.M., Gale N.W., Yancopoulos G.D., Alvarez-Buylla A. Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nat. Neurosci. 3:2000;1091-1097.
7. Craig C.G., Tropepe V., Morshead C.M., Reynolds B.A., Weiss S., van der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J. Neurosci. 16:1996;2649-2658.
8. +/- mice. Science. 285:1999;2122-2125.
9. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19:1998;348-355.
10. Eng C., Murday V., Seal S., Mohammed S., Hodgson S.V., Chardary M.A., Fentiman I.S., Ponder B.A.J., Eeles R.A. Cowden syndrome and Lhermitte-Duclos disease in a family a single genetic syndrome with pleiotropy? J. Med. Genet. 31:1994;458-461.
11. Francis F., Koulakoff A., Boucher D., Chafey P., Schaar B., Vinet M.C., Friocourt G., McDonnell N., Reiner O., Kahn A., McConnell S.K., Berwald-Netter Y., Denoulet P., Chelly J. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron. 23:1999;247-256.
12. Freeman D.J., Li A.G., Wei G., Li H.H., Kertesz N., Lesche R., Whale A.D., Martinez-Diaz H., Rozengurt N., Cardiff R.D., Liu X., Wu H. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell. 3:2003;117-130.
13. 1 growth arrest in glioma cells. Cancer Res. 58:1998;5002-5008.
14. Gary D.S., Mattson M.P. PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis. Neuromol. Med. 2:2002;261-269.
15. Geschwind D.H., Ou J., Easterday M.C., Dougherty J.D., Jackson R.L., Chen Z., Antoine H., Terskikh A., Weissman I.L., Nelson S.F., Kornblum H.I. A genetic analysis of neural progenitor differentiation. Neuron. 29:2001;325-339.
16. Gleeson J.G., Lin P.T., Flanagan L.A., Walsh C.A. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 23:1999;257-271.
17. Gomez-Manzano C., Fueyo J., Jiang H., Glass T.L., Lee H.Y., Hu M., Liu J.L., Jasti S.L., Liu T.J., Conrad C.A., Yung W.K. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann. Neurol. 53:2003;109-117.
18. Gorlin R.J., Cohen M.M., Condon L.M., Burke B.A. Bannayan-Riley- Ruvalcaba syndrome. Am. J. Med. Genet. 44:1992;307-314.
19. Groszer M., Erickson R., Scripture-Adams D.D., Lesche R., Trumpp A., Zack J.A., Kornblum H.I., Liu X., Wu H. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science. 294:2001;2186-2189.
20. Gustin J.A., Maehama T., Dixon J.E., Donner D.B. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor κB activity. J. Biol. Chem. 276:2001;27740-27744.
21. Hitoshi S., Alexson T., Tropepe V., Donoviel D., Elia A.J., Nye J.S., Conlon R.A., Mak T.W., Bernstein A., van Der Kooy D. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 16:2002;846-858.
22. Hong T.M., Yang P.C., Peck K., Chen J.J., Yang S.C., Chen Y.C., Wu C.W. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. Am. J. Respir. Cell Mol. Biol. 23:2000;355-363.
23. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., Lemischka I.R. A stem cell molecular signature. Science. 298:2002;601-604.
24. Jin K., Minami M., Lan J.Q., Mao X.O., Batteur S., Simon R.P., Greenberg D.A. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. USA. 98:2001;4710-4715.
25. Koul D., Yao Y., Abbruzzese J.L., Yung W.K., Reddy S.A. Tumor suppressor mmac/pten inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway. J. Biol. Chem. 276:2001;11402-11408.
26. Kramer P.R., Wray S. Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons. Genes Dev. 14:2000;1824-1834.
27. Kruse N., Pette M., Toyka K., Rieckmann P. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J. Immunol. Methods. 210:1997;195-203.
28. Kulkarni S.V., Gish G., van der Geer P., Henkemeyer M., Pawson T. Role of p120 Ras-GAP in directed cell movement. J. Cell Biol. 149:2000;457-470.
29. Kurose K., Zhou X.P., Araki T., Cannistra S.A., Maher E.R., Eng C. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am. J. Pathol. 158:2001;2097-2106.
30. Kwon C.H., Zhu X., Zhang J., Knoop L.L., Tharp R., Smeyne R.J., Eberhart C.G., Burger P.C., Baker S.J. Pten regulates neuronal soma size a mouse model of Lhermitte-Duclos disease . Nat. Genet. 29:2001;404-411.
31. Lachyankar M.B., Condon P.J., Quesenberry P.J., Litofsky N.S., Recht L.D., Ross A.H. Embryonic precursor cells that express Trk receptors induction of different cell fates by NGF, BDNF, NT-3, and CNTF . Exp. Neurol. 144:1997;350-360.
32. Lachyankar M.B., Sultana N., Schonhoff C.M., Mitra P., Poluha W., Lambert S., Quesenberry P.J., Litofsky N.S., Recht L.D., Nabi R., Miller S.J., Ohta S., Neel B.G., Ross A.H. A role for nuclear PTEN in neuronal differentiation. J. Neurosci. 20:2000;1404-1413.
33. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
34. Li L., Liu F., Ross A.H. PTEN regulation of neural development and CNS stem cells. J. Cell. Biochem. 88:2003;24-28.
35. Li L., Liu F., Salmonsen R.A., Turner T.K., Litofsky N.S., Di Cristofano A., Pandolfi P.P., Jones S.N., Recht L.D., Ross A.H. PTEN in neural precursor cells regulation of migration, apoptosis, and proliferation . Mol. Cell. Neurosci. 20:2002;21-29.
36. Liaw D., Marsh D.J., Li J., Dahia P.L.M., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:1997;64-67.
37. Liliental J., Moon S.Y., Lesche R., Mamillapalli R., Li D., Zheng Y., Sun H., Wu H. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10:2000;401-404.
38. Lim D.A., Tramontin A.D., Trevejo J.M., Herrera D.G., Garcia-Verdugo J.M., Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron. 28:2000;713-726.
39. Lois C., Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science. 264:1994;2074-2077.
40. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 273:1998;13375-13378.
41. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., DePinho R.A. Malignant glioma genetics and biology of a grave matter . Genes Dev. 15:2001;1311-1333.
42. Marino S., Krimpenfort P., Leung C., Van Der Korput H.A., Trapman J., Camenisch I., Berns A., Brandner S. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development. 129:2002;3513-3522.
43. Matsushima-Nishiu M., Unoki M., Ono K., Tsunoda T., Minaguchi T., Kuramoto H., Nishida M., Satoh T., Tanaka T., Nakamura Y. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN. Cancer Res. 61:2001;3741-3749.
44. Mayo L.D., Dixon J.E., Durden D.L., Tonks N.K., Donner D.B. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277:2002;5484-5489.
45. Melnyk O., Shuman M.A., Kim K.J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 56:1996;921-924.
46. Myers M.P., Pass I., Batty I.H., Van der Kaay J., Stolarov J.P., Hemmings B.A., Wigler M.H., Downes C.P., Tonks N.K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA. 95:1998;13513-13518.
47. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., Sellers W.R. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20:2000;8969-8982.
48. Pencea V., Bingaman K.D., Wiegand S.J., Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J. Neurosci. 21:2001;6706-6717.
49. Persad S., Troussard A.A., McPhee T.R., Mulholland D.J., Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of β-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol. 153:2001;1161-1174.
50. Rabbany S.Y., Heissig B., Hattori K., Rafii S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol. Med. 9:2003;109-117.
51. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A. "Stemness:" transcriptional profiling of embryonic and adult stem cells . Science. 298:2002;597-600.
52. Recht L., Jang T., Savarese T., Litofsky N.S. Neural stem cells and neuro-oncology Quo vadis? J. Cell. Biochem. 88:2003;11-19.
53. Reynolds B.A., Tetzlaff W., Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12:1992;4565-4574.
54. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 255:1992;1707-1710.
55. Sawada K., Morishige K., Tahara M., Ikebuchi Y., Kawagishi R., Tasaka K., Murata Y. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells. Gynecol. Oncol. 87:2002;252-259.
56. Semenza G.L. Hypoxia-inducible factor 1 oxygen homeostasis and disease pathophysiology . Trends Mol. Med. 7:2001;345-350.
57. Shingo T., Gregg C., Enwere E., Fujikawa H., Hassam R., Geary C., Cross J.C., Weiss S. Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science. 299:2003;117-120.
58. Shingo T., Sorokan S.T., Shimazaki T., Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21:2001;9733-9743.
59. Stambolic V., Suzuki A., Lois de la Pompa J., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:1998;29-39.
60. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H.F., Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:1997;356-362.
61. Stolarov J., Chang K., Reiner A., Rodgers L., Hannon G.J., Wigler M.H., Mittal V. Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc. Natl. Acad. Sci. USA. 98:2001;13043-13048.
62. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., Mak T.W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8:1998;1169-1178.
63. Trepicchio W.L., Ozawa M., Walters I.B., Kikuchi T., Gilleaudeau P., Bliss J.L., Schwertschlag U., Dorner A.J., Krueger J.G. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J. Clin. Invest. 104:1999;1527-1537.
64. Tropepe V., Craig C.G., Morshead C.M., van der Kooy D. Transforming growth factor-α null and senescent mice show decreased neural progenitor cell proliferation in the forebrain subependyma. J. Neurosci. 17:1997;7850-7859.
65. Virgintino D., Errede M., Robertson D., Girolamo F., Masciandaro A., Bertossi M. VEGF expression is developmentally regulated during human brain angiogenesis. Histochem. Cell. Biol. 119:2003;227-232.
66. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-κB antiapoptosis induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation . Science. 281:1998;1680-1683.
67. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., Semenza G.L. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAPpathway in human prostate cancer cells implications for tumor angiogenesis and therapeutics . Cancer Res. 60:2000;1541-1545.
68. Zundel W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E., Gottschalk A.R., Ryan H.E., Johnson R.S., Jefferson A.B., Stokoe D., Giaccia A.J. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14:2000;391-396.